BDSX (Biodesix, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by BDSX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | JACK W SCHULER | 10%+ Owner | Buy | — | — |
| 2026-08-12 | JACK W SCHULER | 10%+ Owner | Buy | — | — |
| 2026-07-02 | JOHN PATIENCE | Director | M | — | — |
| 2026-04-02 | JOHN PATIENCE | Director | M | — | — |
| 2026-02-23 | Kieran O'Kane | Chief Commercial Officer | MIXED | — | — |
| 2026-02-23 | Scott Hutton | President & CEO | MIXED | — | — |
| 2026-02-23 | Robin Harper Cowie | CFO, Sec'y & Treasurer | MIXED | — | — |
| 2026-02-23 | Chris Vazquez | Chief Accounting Officer | MIXED | — | — |
| 2026-02-23 | Gary Anthony Pestano | Chief Development Officer | MIXED | — | — |
| 2026-02-11 | Kieran O'Kane | Chief Commercial Officer | MIXED | — | — |
| 2026-02-11 | Scott Hutton | President & CEO | MIXED | — | — |
| 2026-02-11 | Gary Anthony Pestano | Chief Development Officer | MIXED | — | — |
| 2026-02-11 | Robin Harper Cowie | CFO, Sec'y & Treasurer | MIXED | — | — |
| 2026-02-11 | Chris Vazquez | Chief Accounting Officer | MIXED | — | — |
| 2026-01-27 | JACK W SCHULER | 10%+ Owner | Buy | — | — |
| 2026-01-26 | JACK W SCHULER | 10%+ Owner | Buy | — | — |
| 2026-01-20 | Robin Harper Cowie | CFO, Sec'y & Treasurer | MIXED | — | — |
| 2026-01-20 | Scott Hutton | President & CEO | MIXED | — | — |
| 2026-01-20 | Gary Anthony Pestano | Chief Development Officer | MIXED | — | — |
| 2026-01-20 | Kieran O'Kane | Chief Commercial Officer | MIXED | — | — |
| 2026-01-20 | Chris Vazquez | Chief Accounting Officer | MIXED | — | — |
| 2026-01-06 | Kieran O'Kane | Chief Commercial Officer | A | — | — |
| 2026-01-06 | Scott Hutton | President & CEO | A | — | — |
| 2026-01-06 | Robin Harper Cowie | CFO, Sec'y & Treasurer | A | — | — |
| 2026-01-06 | HANY MASSARANY | Director | A | — | — |
| 2026-01-06 | JOHN PATIENCE | Director | M | — | — |
| 2026-01-06 | Jean M. Franchi | Director | A | — | — |
| 2026-01-06 | Matthew Strobeck | Director | A | — | — |
| 2026-01-06 | Lawrence T. Kennedy Jr | Director | A | — | — |
| 2026-01-06 | Jon Faiz Kayyem | Director | A | — | — |
| 2026-01-06 | Gary Anthony Pestano | Chief Development Officer | A | — | — |
| 2026-01-06 | Chris Vazquez | Chief Accounting Officer | A | — | — |
| 2025-11-13 | Gary Anthony Pestano | Chief Development Officer | MIXED | — | — |
| 2025-11-13 | Scott Hutton | President & CEO | MIXED | — | — |
| 2025-11-13 | Chris Vazquez | Chief Accounting Officer | MIXED | — | — |
| 2025-11-13 | Robin Harper Cowie | CFO, Sec'y & Treasurer | MIXED | — | — |
| 2025-11-13 | Kieran O'Kane | Chief Commercial Officer | MIXED | — | — |
| 2025-10-02 | JOHN PATIENCE | Director | M | — | — |
| 2025-09-23 | JACK W SCHULER | Director | Buy | — | — |
| 2025-09-19 | JACK W SCHULER | Director | Buy | — | — |
| 2025-09-03 | JACK W SCHULER | Director | Buy | — | — |
| 2025-08-14 | Scott Hutton | President & CEO | MIXED | — | — |
| 2025-08-14 | Gary Anthony Pestano | Chief Development Officer | MIXED | — | — |
| 2025-08-14 | Robin Harper Cowie | CFO, Sec'y & Treasurer | MIXED | — | — |
| 2025-08-14 | Chris Vazquez | Chief Accounting Officer | MIXED | — | — |
| 2025-08-14 | Kieran O'Kane | Chief Commercial Officer | MIXED | — | — |
| 2025-07-02 | HANY MASSARANY | Director | M | — | — |
| 2025-07-02 | JOHN PATIENCE | Director | M | — | — |
| 2025-05-22 | HANY MASSARANY | Director | A | — | — |
| 2025-05-22 | Lawrence T. Kennedy Jr | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 555,810 | — |
| — | Director | 138,769 | — |
| — | Director | 133,096 | — |
| — | President & CEO | 50,257 | — |
| — | Director | 28,032 | — |
| — | Director | 21,085 | — |
| — | Director | 18,175 | — |
| — | Director | 17,877 | — |
| — | CFO, Sec'y & Treasurer | 16,231 | — |
| — | Chief Development Officer | 10,359 | — |
| — | Chief Commercial Officer | 9,819 | — |
| — | Director | 5,407 | — |
| — | Chief Accounting Officer | 2,042 | — |
| — | Chief Scientific Officer | 1,911 | — |
| — | Chief Accounting Officer | 1,586 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BDSX quote page; the site-wide leaderboard is on the insider transactions hub.